Literature DB >> 16359542

Postradiation vascular proliferations: an increasing problem.

T Brenn1, C D M Fletcher.   

Abstract

The occurrence of cutaneous vascular lesions is a rare but well-documented complication of radiation treatment and may be associated with significant morbidity as well as mortality. The overall incidence is low but appears to be rising due to a change in the prevailing treatment of breast carcinoma with increased use of radiation in the setting of breast-conserving therapy for stage 1 and 2 disease. The spectrum of postradiation vascular lesions is wide and ranges from atypical vascular lesions with reportedly benign clinical behaviour to frank cutaneous angiosarcoma. There is, however, significant clinical as well as histological overlap. It is frequently difficult to classify these postradiation vascular lesions accurately and they create an emerging diagnostic and therapeutic challenge to both pathologists and clinicians. Experience with these vascular lesions is very limited, and this article aims to provide an overview of our current understanding and concept of radiation-associated vascular lesions with focus on their clinical and histological presentation as well as behaviour and treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16359542     DOI: 10.1111/j.1365-2559.2005.02293.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  23 in total

Review 1.  Prevention of pelvic radiation disease.

Authors:  Lorenzo Fuccio; Leonardo Frazzoni; Alessandra Guido
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-02-06

Review 2.  [Cutaneous angiosarcoma: new aspects].

Authors:  T Brenn
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 3.  Angiosarcoma: clinical and imaging features from head to toe.

Authors:  Ayman H Gaballah; Corey T Jensen; Sarah Palmquist; Perry J Pickhardt; Alper Duran; Gregory Broering; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

4.  Thalidomide combined with neoadjuvant chemotherapy in angiosarcoma of the breast with complete pathologic response: case report and review of literature.

Authors:  Alberto Alvarado-Miranda; Ludwing Bacon-Fonseca; Fernando Ulises Lara-Medina; Hector Maldonado-Martínez; Claudia Arce-Salinas
Journal:  Breast Care (Basel)       Date:  2013-03       Impact factor: 2.860

5.  Post-radiation atypical vascular lesion/angiosarcoma arising in the larynx.

Authors:  K M Mudaliar; R Borrowdale; S Mehrotra
Journal:  Head Neck Pathol       Date:  2013-12-06

6.  Four cases of echogenic breast lesions: a case series and review.

Authors:  Lin Wah Goh; Su Lin Jill Wong; Puay Hoon Tan
Journal:  Singapore Med J       Date:  2016-02-19       Impact factor: 1.858

7.  Clinical management of secondary angiosarcoma after breast conservation therapy.

Authors:  Martina Zemanova; Katarina Machalekova; Monika Sandorova; Elena Boljesikova; Marta Skultetyova; Juraj Svec; Andrej Zeman
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-23

8.  Bilateral angiosarcoma of the breast detected by magnetic resonance imaging during pregnancy.

Authors:  Takeo Fujita; Naruto Taira; Yutaka Ogasawara; Masako Omori; Hiroyoshi Doihara
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

9.  Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

Authors:  Benjamin H Kaffenberger; Rena C Zuo; Alejandro Gru; Alisha N Plotner; Sarah A Sweeney; Steven M Devine; Sharon R Hymes; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2014-07-01       Impact factor: 11.527

10.  Breast angiosarcoma secondary to phyllodes tumour.

Authors:  Sílvia Costa; Susana Alexandra Rodrigues Graça; António Ferreira; Jorge Maciel
Journal:  BMJ Case Rep       Date:  2012-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.